Member Info for bigAl67

Genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to announce that Manchester University NHS Foundation Trust ("MFT") hospitals has transitioned the Genedrive® MT-RNR1 ID kit for the prevention of Antibiotic Induced Hearing Loss in neonates to Business as Usual ("BAU") routine clinical service.

Genedrivegenedrive

5,672 followers5,672 followers

Visit website

3d • 3 days ago • Visible to anyone on or off LinkedIn

Greater Manchester is showing what’s possible when innovation is connected to delivery.

As our CEO Dr Gino Miele highlights, the next step is scaling prevention-led diagnostics so patients benefit consistently across the NHS.

At genedrive, our focus is on enabling earlier, more informed treatment decisions, whether identifying stroke patients who may not respond to standard therapy or supporting safer prescribing in neonatal care.

The focus now must be implementation at scale.

View Gino Miele’s graphic link

Gino MieleGino Miele

• 2ndVerified • 2nd

CEO / CSO, genedriveCEO / CSO, genedrive

3d • 3 days ago • Visible to anyone on or off LinkedIn

Follow

Greater Manchester has long led in genomics. The opportunity now is turning that strength into consistent, real-world patient benefit.

The new Prevention Demonstrator status is a step in the right direction, helping proven innovations reach patients faster while reducing pressure on the NHS.

At genedrive, we’ve seen how rapid pharmacogenetic testing can support time-critical decisions, from guiding antiplatelet therapy after stroke to informing safer antibiotic use in newborns.

As the NHS shifts towards prevention, the priority must be clear pathways to adoption so innovation becomes standard of care, not just pilots.

https://lnkd.in/eRDv-8Cq

Manchester, UK - 19 February 2026: genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, announces that further to the announcement on 13 February 2026 confirming the completion of the Placing, a Circular will shortly be published on the Company's website, www.genedrive.com, and will be posted to Shareholders later today. The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. on 9 March 2026.

Hi stephen11,

Yes agreed this is a better deal than the 0.20p proposal. It is Good to have the backing of two astute Business men.

We do not know the full details of the offer yet, such as the costs involved with the 'launch, and the successful completion' of the raise? Will the raise result in a clear £6 mil in the bank?, or will the raise result in the costs to be taken from the £6mil raise? We do not know the offer price per share?

Either way I prefer to see a £6mil raise now, rather than the proposed £3mil raise suggested, and rejected previously !

The more money we raise now the better is my thoughts ?!

The future does look Brighter for sure !!

Hi stephen11,

The RNS 5th December 2025 states average cash burn is c.£350,000 per month.

Therefore, Cash of £320,000 as at 30th November 2025, Plus £500,000 loan from DN in Dec 2025 = £820,000 (The £500,000 Loan from DN will be converted into shares, so no need to be paid back).

£820,000 - £350,000 cash burn in Dec 2025 = £470,000 cash in bank as at 31st Dec 2025

£470.000 - £350,000 cash burn in January 2026 = £120,000 cash in bank as at 31st January 2026.

Therefore, providing we raise £6mil in Feb 2026, our total cash = £6,120,000.

£6,120,000 divided by £350,000 average cash burn per month = 17.48 months from 1st February 2026 (agreed)!! This status takes us to Mid-July 2027 !!

Of course sales revenue plus Tax refunds extends cash in bank, hopefully to a status of self-financing in 2027 !!!

RNS 19th Jan 2026.

Mr. Nugent also intends to convert the '£500,000 loan provided to the Company last month' into new equity at the issue price of the Equity Raise. Mr Nugent intends that his beneficial shareholding post the Equity Raise / loan conversion will remain at less than 30% of the Company's voting rights.

RNS 9th December 2025.

Agreement of Shareholder Loan

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to announce that further to the announcement of 19 November 2025 confirming that heads of term had been agreed for a potential shareholder loan (the "Loan") from David Nugent, a significant shareholder in the Company, the Company is pleased to confirm today that definitive agreements have now been signed for the Loan.

Further terms of the Loan and Related Party Transaction

The Company and David Nugent have entered into a Loan Agreement for up to £1.0 million in value (the "Loan"). The Loan is available to be drawn in two equal tranches of £500,000. The first tranche shall be requested imminently and shall not attract any commitment fee, interest or charges. The first tranche is expected to extend the Company's cash runway into February 2026. The second tranche will be available to be drawn down at the request and discretion of the Company on or after 20 February 2026 (or such other date as may be agreed between the Company and David Nugent). Draw down of the second tranche would incur a fixed fee of £50,000 which shall be added to the amount of principal and would need to be repaid upon repayment or conversion of the second tranche. The loan shall be secured by the grant of a debenture over all the Company's assets and is for a maximum period of twelve months. David Nugent currently intends that all amounts of the Loan drawn down shall be converted into equity as part of a future equity raise.

RNS 5th December 2025.

Financial position

§ Cash position at 30 November 2025 of £0.32m relative to an average monthly cash burn of c. £0.35m.

§ Heads of terms agreed for a £1m loan from the Company's largest shareholder and discussions are progressing to finalise this.

Great news, and the £500k loan will be converted into shares at around current price - Therefore back to No Debt !!

Together with the Board putting in a minimum of £100k, confidence is High !!

I was concerned that once the up to £1mil loan ran out in March?, and if no further finance put forward, the debt would possibly be financed by the value of our 2 Products, on the cheap??

HI Stephen,

It is because of Posters like these, that I do not bother wasting my time Posting, generally - 'cashburn was reduced to £350/mth at the last minute' - so an admission by spantrout that he Lied, when he posted it is £500k per month - once a proven liar - always a proven Liar !!

I hope all is well with you stephen !

@ Money888 and Prof - QED Guys - QED.

@Spantrout,

You are a Good example of the sort of Poster that should not be taken seriously. You obviously have no idea, and post absolute made up rubbish.

Firstly the Cash Burn is Not £500k per month - it has been reduced to £350k per month, and this at a time when the BOD were saying there is a need to increase our Cash Burn to £650k per month.

Secondly the BOD have agreed to a 10% deferred pay cut - so go and do some research, and consider posting Truth rather than your made up Lies .

Hi Stephen,

Yes still here, and still invested in GDR.

Personally, I voted 'FOR' all the Boards recommendations.

I do not understand how a 'NO' vote is a credible option, based on What? - To recognise that we do not know what David's Funding/Financing ideas are, But we should vote NO, and support him, because he has invested a lot of Money is Crazy, IMHO.

Posters saying our Board are useless with out giving specific examples, should not be taken seriously, especially as I believe most of these Posters are not even invested in GDR IMHO.

It is the NHS and NICE that are causing the delays in Product Orders - Not our BOD IMHO.

The Great News is:- The Real News - Our SP is going up strongly, and has been for >A Year now !!!

Market Summary >

BT Group - CLASS A Common Stock

209.40 GBX

+10.00 (5.02%)today

24 Jul, 08:57 BST • Disclaimer

Open

199.40

High

208.20

Low

199.40

Mkt cap

20.72B

P/E ratio

19.65

Div yield

3.92%

52-wk high

208.20

52-wk low

125.81

Qtrly div amt

2.04

"BT has had a solid start to the year, with our full fibre broadband now reaching more than 19 million homes and businesses and our 5G network available to over 87% of the UK population. We're seeing strong customer demand for our next-generation broadband and mobile connectivity across all our brands, with record Openreach fibre take-up again this quarter. And we're delivering on our transformation, as we radically simplify our business while improving customer experience.

"BT is investing more than anyone else in the nation's networks, we're connecting customers faster, and we're on track to deliver our targets for this year, next year, and the end of the decade - creating a better BT, for all of us."

Market Summary >

Genedrive PLC

2.34 GBX

+0.14 (6.36%)today

29 Jan, 08:49 GMT • Disclaimer

AH SO - Gloria Market and stocksaint (AKA Starresstoff) increased Squirming negatively with our SP showing some positive upward movement - Double Whammy - Love it !! LOL

''At one point I was up well over £300k though on paper......''

AH SO - stocksaint, that is the True reason why you Despise Our Genedrive so much - You Blame Our GDR for You Loosing £300,000 of Paper Profit....... - No wonder you are up All Hours of the Day and Night Posting Rubbish.

Well chap I have news for You - It was You who lost that £300,000, and Not Our GDR Chap.

Oh dear - Release of the Krakens - They come out when a member of their Group is Feeling the Pain !! LOL

Still Merry Christmas to you all too !!

Sorry to read of the Pain you are in StockSaint (aka Starrenstoff) - 'I wish I had the drugs you're on to make up that crap' ''Then I would never have any pain again.'' - This pain you mention is Most Likely brought on by the Made Up Rubbish you Post, all hours of the Night and Day.

Try taking a Break, and a Rest from Posting about a Share you do not own.

Merry Christmas, and a Happy New Year - Chap !!

The last 10 Trades yesterday showing our SP did indeed go up after the 994,000 share trade !

Date Time Trade Prc Volume Buy/Sell Bid Ask Value

04-Dec-24 16:18:38 2.01 96,373 Buy* 1.95 2.05 1,937 O

04-Dec-24 15:59:56 2.01 1,500 Buy* 1.95 2.05 30.15 O

04-Dec-24 15:16:20 2.02 150,000 Buy* 1.95 2.05 3,030 O

04-Dec-24 14:35:31 1.972 170,000 Sell* 1.95 2.05 3,352 O

04-Dec-24 13:53:17 2.019 50,000 Buy* 1.95 2.05 1,010 O

04-Dec-24 13:23:09 2.019 1,884 Buy* 1.95 2.05 38.04 O

04-Dec-24 13:02:04 2.019 10,000 Buy* 1.95 2.05 201.90 O

04-Dec-24 12:47:54 2.00 994,000 Unknown* 1.95 2.05 19.88k O

04-Dec-24 12:43:47 1.967 350,000 Sell* 1.95 2.05 6,885 O

04-Dec-24 12:38:30 2.019 48,538 Buy* 1.95 2.05 979.98

Mondays last 5 Trades:-

Date Time Trade Prc Volume Buy/Sell Bid Ask Value

02-Dec-24 16:40:26 1.83 246,078 Sell* 1.90 1.95 4,503

02-Dec-24 16:22:18 1.94 1,030 Buy* 1.90 1.95 19.98

02-Dec-24 16:21:41 1.94 5,154 Buy* 1.90 1.95 99.99

02-Dec-24 16:13:27 1.91 432,516 Sell* 1.90 1.95 8,261

02-Dec-24 15:12:00 1.85751 1,688,291 Unknown* 1.90 1.95 31.36k